SETBP1 mutations have been shown to be a poor prognostic factor in chronic neutrophilic leukemia (CNL) which is a rare myeloproliferative leukemia (Gao et al., 2022). This evidence concerns the gene SETBP1 and chronic neutrophilic leukemia.